Equillium (EQ) Interest & Investment Income (2018 - 2026)
Equillium (EQ) posted quarterly Interest & Investment Income of $309000.0 for Q1 2026, up 78.61% year-over-year from $173000.0 in Q1 2025, and up 31.49% quarter-over-quarter from $235000.0 in Q3 2025.
Equillium (EQ) Interest & Investment Income (2018 - 2026) Analysis & Trends
Equillium (EQ) has reported Interest & Investment Income for 9 consecutive years, with $309000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Interest & Investment Income rose 78.61% year-over-year to $309000.0; the TTM figure through Mar 2026 stood at $666000.0 (up 272.07% YoY), while the FY2025 annual figure was -$3000.0, up 80.0% from the prior year.
- Interest & Investment Income improved to $309000.0 in Q1 2026 per EQ's latest filing, from $235000.0 in the prior quarter.
- Across five years, Interest & Investment Income topped out at $309000.0 in Q1 2026 and bottomed at -$257000.0 in Q4 2022.
- Historically, Interest & Investment Income has averaged $35687.5 across 5 years, with a median of $20000.0 in 2023.
- On a YoY basis, Interest & Investment Income climbed as much as 4433.33% in 2022 and fell as far as 2670.0% in 2022.
- Equillium's Interest & Investment Income stood at -$257000.0 in 2022, then surged by 111.67% to $30000.0 in 2023, then slumped by 130.0% to -$9000.0 in 2024, then surged by 2711.11% to $235000.0 in 2025, then soared by 31.49% to $309000.0 in 2026.
- Business Quant data shows EQ's Interest & Investment Income at $309000.0 in Q1 2026, $235000.0 in Q3 2025, and $122000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 48.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 35.58 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 27.90 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 5.13 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 28.14 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 10.98 Mn |
| 10 | Equillium | 263.86 Mn | 263.86 Mn | - | 509,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 509,000.00 |
| Mar 31, 2026 | 309,000.00 |
| Sep 30, 2025 | 235,000.00 |
| Jun 30, 2025 | 122,000.00 |
| Mar 31, 2025 | 173,000.00 |
| Dec 31, 2024 | -9,000.00 |
| Sep 30, 2024 | 21,000.00 |
| Jun 30, 2024 | -6,000.00 |
| Mar 31, 2024 | -22,000.00 |
| Dec 31, 2023 | 30,000.00 |
| Sep 30, 2023 | 19,000.00 |
| Jun 30, 2023 | -36,000.00 |
| Mar 31, 2023 | 96,000.00 |
| Dec 31, 2022 | -257,000.00 |
| Sep 30, 2022 | 130,000.00 |
| Jun 30, 2022 | -54,000.00 |
| Mar 31, 2022 | -180,000.00 |
| Dec 31, 2021 | 10,000.00 |
| Sep 30, 2021 | -3,000.00 |
| Jun 30, 2021 | 13,000.00 |